BRUNETTI, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 1.071
EU - Europa 1.068
AS - Asia 342
SA - Sud America 37
AF - Africa 8
Totale 2.526
Nazione #
US - Stati Uniti d'America 1.068
RU - Federazione Russa 694
HK - Hong Kong 122
IE - Irlanda 105
IT - Italia 103
SG - Singapore 98
CN - Cina 77
SE - Svezia 76
BR - Brasile 36
GB - Regno Unito 32
IN - India 32
DE - Germania 16
FR - Francia 10
BE - Belgio 8
AT - Austria 7
NL - Olanda 7
CI - Costa d'Avorio 6
FI - Finlandia 6
KR - Corea 4
PK - Pakistan 4
CA - Canada 2
AZ - Azerbaigian 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 2.526
Città #
Chandler 338
Hong Kong 122
Dublin 99
Ashburn 81
Boardman 80
Fairfield 48
The Dalles 48
Singapore 46
Ancona 36
Lawrence 35
Princeton 35
Pune 32
Moscow 30
Wilmington 30
Los Angeles 18
Cambridge 16
London 16
Montesilvano Marina 15
Des Moines 14
Nuremberg 12
Bologna 11
Shanghai 10
Washington 10
Woodbridge 10
San Diego 9
Brussels 8
Dallas 8
Haikou 8
Houston 7
Seattle 7
Abidjan 6
Helsinki 6
New York 6
Rome 6
San Vitaliano 6
Beijing 5
Guangzhou 5
São Paulo 5
Ann Arbor 4
Jiaxing 4
Acton 3
Perugia 3
Prescot 3
Vienna 3
Wuhan 3
Belo Horizonte 2
Boston 2
Buffalo 2
Hounslow 2
Kilburn 2
Milan 2
Porto Alegre 2
Rio de Janeiro 2
Sacramento 2
San Francisco 2
Santa Clara 2
Seoul 2
Shenzhen 2
Tianjin 2
Verona 2
Vitória 2
Wuxi 2
Yuseong-gu 2
Amsterdam 1
Aracaju 1
Asunción 1
Atlanta 1
Aversa 1
Baku 1
Brooklyn 1
Caieiras 1
Changsha 1
Charlotte 1
Cuiabá 1
Curitiba 1
Dalian 1
Duque de Caxias 1
Florianópolis 1
Garça 1
Guarulhos 1
Haimen 1
Heze 1
Hortolândia 1
Islington 1
Jinhua 1
Johannesburg 1
Linyi 1
Longyan 1
Manassas 1
Manaus 1
Manchester 1
Marco 1
Maricá 1
Mogi Mirim 1
Morada Nova de Minas 1
Nanyang 1
Niterói 1
Norwalk 1
Panama City 1
Paudalho 1
Totale 1.380
Nome #
Highly efficient gene disruption of murine and human hematopoietic progenitor cells by CRISPR/Cas9 644
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 107
NPM1-mutated acute myeloid leukemia: From bench to bedside 85
How I diagnose and treat NPM1-mutated AML 71
Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics 67
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression 63
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 60
Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy 53
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells 52
Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field 52
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9 51
Response to: “Cytoplasmic dislocation of NPM1 and PU.1 in NPM1-mutated leukemia is obscured by paraformaldehyde fixation” 50
CD123 is consistently expressed on NPM1-mutated AML cells 49
DNMT3A in Leukemia 47
Aerobic Plus Resistance Exercise in Obese Older Adults Improves Muscle Protein Synthesis and Preserves Myocellular Quality Despite Weight Loss 47
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice 46
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 44
Mutant NPM1 directly regulates oncogenic transcription in acute myeloid leukemia 43
Nutrient-sensitive transcription factors TFEB and TFE3 couple autophagy and metabolism to the peripheral clock 43
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 43
It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice 42
CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells: Correspondence 41
Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities 40
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome 40
Current status and future perspectives in targeted therapy of NPM1-mutated AML 39
PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1 39
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 39
NOVEL NPM1 EXON 5 MUTATIONS AND GENE FUSIONS LEADING TO ABERRANT CYTOPLASMIC NUCLEOPHOSMIN IN AML 38
TFEB regulates murine liver cell fate during development and regeneration 37
Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptor 37
Dactinomycin in NPM1-Mutated acute myeloid leukemia 36
Effect of the COVID-19 pandemic on laboratory and clinical research: A testimony and a call to action from researchers 36
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein 34
AML-099 Prolonged XPO1 Inhibition Is Essential for Optimal Anti-Leukemic Activity in NPM1-Mutated AML 34
Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma 34
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells 32
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: A shared clonal origin 31
Mutant NPM1 Maintains the Leukemic State through HOX Expression 31
New insights into the biology of acute myeloid leukemia with mutated NPM1 28
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion 28
null 27
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 24
Overlapping features of therapy-related and de novoNPM1-mutated AML 20
An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variant 18
Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cells 18
NPM1-mutated AML with starry sky pattern 18
Mutant NPM1: Nuclear export and the mechanism of leukemogenesis 17
Breast Cancer With Release of Tumor Cells in Peripheral Blood Mimicking Acute Myeloid Leukemia 17
The NPM1 mutant defines AML irrespective of blast count 14
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A 12
Prolonged XPO1 inhibition is essential for optimal anti-leukemic activity in NPM1-mutated AML 3
Totale 2.621
Categoria #
all - tutte 19.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 3 0
2021/2022288 0 18 0 0 53 48 1 11 49 8 22 78
2022/2023689 67 80 49 77 49 64 6 57 171 2 29 38
2023/2024970 80 15 37 50 48 205 130 132 77 98 56 42
2024/2025671 77 76 13 18 19 45 72 60 175 44 72 0
Totale 2.621